Impact of tumour necrosis factor inhibitor treatment on hand bone loss in rheumatoid arthritis patients treated in clinical practice: results from the nationwide Danish DANBIO registry

被引:0
|
作者
Ornbjerg, L. M. [1 ]
Ostergaard, M. [1 ]
Boyesen, P. [2 ]
Jensen, T. [3 ]
Thormann, A. [1 ]
Tarp, U. [1 ]
Bohme, W. [1 ]
Dencker, D. [1 ]
Lindegaard, H. [1 ]
Poulsen, U. E. [1 ]
Hansen, A. [1 ]
Ringsdal, V. [1 ]
Schlemmer, A. [4 ]
Graudal, N. [1 ]
Andersen, A. R. [1 ]
Espesen, J. [1 ]
Kollerup, G. [1 ]
Christensen, T. [1 ]
Pelck, R. [1 ]
Glintborg, B. [1 ]
Madsen, O. [1 ]
Jensen, D. V. [1 ]
Majgaard, O. [1 ]
Hetland, M. [1 ]
机构
[1] DANBIO, Copenhagen, Denmark
[2] Diakonhjemmet Hosp, Oslo, Norway
[3] Hvidovre Univ Hosp, Copenhagen, Denmark
[4] Dept Rheumatol, Copenhagen, Denmark
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
PP121
引用
收藏
页码:27 / 28
页数:2
相关论文
共 50 条
  • [31] Risk of Neurological Adverse Events during Tumour Necrosis Factor Inhibitor Treatment for Arthritis: A Population-Based Cohort Study from Danbio and the Danish National Patient Registry
    Dreyer, Lene
    Kopp, Tine Iskov
    Jacobsen, Rikke Kart
    Magyari, Melinda
    Ibfelt, Else Helene
    Locht, Henning
    Sellebjerg, Finn Thorup
    Jensen, Dorte Vendelbo
    Cordtz, Rene
    [J]. ARTHRITIS & RHEUMATOLOGY, 2018, 70
  • [32] Hepatobiliary Events in ≥5000 Patients with Inflammatory Arthritis Treated with Biosimilar or Originator Etanercept in Routine Care, Results from the Danish Nationwide DANBIO Registry
    Glintborg, Bente
    Georgiadis, Stylianos
    Norgaard, Mette
    Mehnert, Frank
    Gron, Kathrine Lederballe
    Krogh, Niels Steen
    Hetland, Merete Lund
    [J]. ARTHRITIS & RHEUMATOLOGY, 2019, 71
  • [33] Low remission rates but long drug survival in rheumatoid arthritis patients treated with infliximab or etanercept: results from the nationwide Danish DANBIO database
    Ostergaard, M.
    Unkerskov, J.
    Linde, L.
    Krogh, N. S.
    Ravn, T.
    Ringsdal, V. S.
    Petri, A.
    Andersen, L. S.
    Tarp, U.
    Hansen, A.
    Hjardem, E.
    Hetland, M. L.
    [J]. SCANDINAVIAN JOURNAL OF RHEUMATOLOGY, 2007, 36 (02)
  • [34] Poor remission rates but long drug survival in rheumatoid arthritis patients treated with infliximab or etanercept - Results from the nationwide Danish "Danbio" database
    Ostergaard, M
    Unkerskov, J
    Krogh, NS
    Friis, M
    Ravn, T
    Petri, A
    Andersen, LS
    Tarp, U
    Hansen, A
    Hetland, ML
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2005, 64 : 59 - +
  • [35] Three-Year Drug Survival and Effectiveness Of Abatacept and Tocilizumab In Patients with Rheumatoid Arthritis Treated In Routine Care. Results From The Nationwide Danish Danbio Registry.
    Leffers, H. C. B.
    Ostergaard, Mikkel
    Glintborg, Bente
    Krogh, Niels Steen
    Tarp, Ulrik
    Lorenzen, Tove
    Hansen, Annette
    Dreyer, Lene
    Hetland, Merete L.
    [J]. ARTHRITIS AND RHEUMATISM, 2013, 65 : S612 - S612
  • [36] ASSOCIATION BETWEEN TOBACCO SMOKING AND RESPONSE TO TUMOR NECROSIS FACTOR ALPHA INHIBITOR TREATMENT IN PSORIATIC ARTHRITIS: RESULTS FROM THE DANBIO REGISTRY
    Hojgaard, P.
    Glintborg, B.
    Hetland, M. L.
    Hansen, T. H.
    Nilsson, C.
    Lage-Hansen, P. R.
    Petersen, M. H.
    Holland-Fisher, M.
    Loft, A. G.
    Andersen, B. N.
    Adelsten, T.
    Jensen, J.
    Omerovic, E.
    Christensen, R.
    Tarp, U.
    Ostgaard, R.
    Dreyer, L.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2014, 73 : 743 - 743
  • [37] Obesity potentially protects against systemic bone loss in patients with rheumatoid arthritis treated with tumour necrosis factor inhibitors
    Lee, S. Y.
    Jung, K-H
    Park, S-G
    Kwon, S-R
    Park, W.
    Lim, M. J.
    [J]. CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2021, 39 (01) : 125 - 131
  • [38] Is treatment response to biologics in rheumatoid arthritis affected by change in prescription practice? Results from the nationwide danbio database
    Hetland, M. L.
    Hansen, A.
    Lindegaard, H.
    Tarp, U.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2007, 66 : 172 - 172
  • [39] Secondary loss of effectiveness among rheumatoid arthritis patients treated with tumour necrosis factor inhibitors
    Aaltonen, K.
    Isomaki, P.
    Joensuu, J.
    Sokka, T.
    Peltomaa, R.
    Piril, L.
    Varjolahti-Lehtinen, T.
    Uutela, T.
    Malmi, T.
    Ekman, P.
    Kononoff, A.
    Eklund, K.
    [J]. SCANDINAVIAN JOURNAL OF RHEUMATOLOGY, 2017, 46 (05) : 419 - 420
  • [40] CLINICAL RESPONSE, DRUG SURVIVAL AND PREDICTORS THEREOF IN 432 PATIENTS WITH ANKYLOSING SPONDYLITIS SWITCHING ANTI TUMOR NECROSIS FACTOR α THERAPY: RESULTS FROM THE DANISH NATIONWIDE DANBIO REGISTRY
    Glintborg, B.
    Ostergaard, M.
    Krogh, N.
    Tarp, U.
    Loft, A.
    Hansen, A.
    Schlemmer, A.
    Fana, V.
    Kristensen, M.
    Lindegaard, H.
    Nordin, H.
    Rasmussen, C.
    Ejstrup, L.
    Petersen, P. M.
    Manilo, N.
    Jensen, D. V.
    Hetland, M. L.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2013, 71 : 111 - 111